Hudson Technologies (HDSN) Q2 2026 earnings review
Volume Growth Overshadowed by Crashing Margins and Swelling Costs
Hudson Technologies delivered an 8% top-line beat driven by robust 12% sales volume growth. However, this volume resilience failed to protect the bottom line, as Net Income decelerated sharply, plunging 52% to $4.9 million. A toxic combination of lower refrigerant prices (-6% YoY), geopolitical inflationary pressures on fuel, and a 33% surge in SG&A expenses severely compressed margins. The cost structure bloat, fueled by ERP optimization, DLA contract legal fees, and consulting, forced management to cut its full-year gross margin guidance. While a new technology partnership with Icorium highlights future product innovation, near-term profitability and cash generation remain under intense pressure.
🐂 Bull Case
Sales volume accelerated 12% in Q2, contributing to a double-digit trailing twelve-month growth rate. Management is effectively winning market share despite an industry trough.
The new Icorium partnership targets extractive distillation to purify complex refrigerant mixtures, positioning Hudson as an early leader in processing next-generation HFO blends.
🐻 Bear Case
SG&A jumped 33% YoY to $12.4M. Continued ERP optimization, legal battles over the DLA contract, and increased consulting fees have broken the company's operating leverage.
Subdued market pricing and fuel inflation forced a downgrade in FY26 gross margin targets from 'mid-twenty percent' to 'low-to-mid-twenty percent,' implying profitability will remain depressed.
⚖️ Verdict: 🔴
Bearish. Double-digit volume growth is an impressive operational feat, but it is entirely hollowed out by crashing pricing, surging overhead, and a deteriorating cash position.
Key Themes
Cost Structure Breakdowns and Margin Reversal
Hudson's operating leverage is reversing. Gross margin collapsed from 31% in 25Q2 to 26% in 26Q2. This was driven by a 6% drop in selling prices (comping against last year's artificial price spikes caused by 454B shortages) and rising fuel costs. Compounding this, SG&A expenses surged 33% to $12.4 million. Management cited ERP system optimization, legal fees for the disputed DLA contract, and new consulting resources. These structural cost increases are severely choking operating income.
Icorium Partnership and Advanced Separation Technology
Management announced a major partnership with Icorium to scale patented extractive distillation technology. This is a critical product innovation required to efficiently process and purify complicated, mixed-refrigerant streams (such as newer HFO blends). If scaled successfully, it will unlock working capital by converting recovered mixed gas into saleable, high-margin certified EMERALD Refrigerants, directly addressing future regulatory shifts.
Persistent Volume Growth Defies Market Softness
Despite broader macroeconomic headwinds and subdued pricing, Hudson is moving significant product. Q2 sales volume grew 12% (accelerating from expectations), marking the second sequential quarter of double-digit volume expansion. This indicates that their strategy of robust inventory availability and customer service is successfully capturing market share in a fragmented landscape.
Macro Subdued Pricing Saps Profitability
The macro narrative relies heavily on the AIM Act HFC phasedown creating a supply shock, but current reality contradicts this. Management openly admitted that 'subdued refrigerant market pricing' is expected to persist through the end of 2026. The 6% YoY decline in selling prices directly caused the lowered annual margin guidance, showing Hudson remains highly vulnerable to commodity-like price swings.
DLA Contract Uncertainty Drags On
The highly lucrative Defense Logistics Agency (DLA) contract remains unresolved after being rescinded due to a competitor's protest in late 2025. Not only is the long-term revenue at risk, but the ongoing dispute is actively draining profits via elevated legal expenses booked in Q2's SG&A.
Other KPIs
Reversing completely from +$20.6 million in the prior-year period. This burn was largely driven by a $26.6 million expansion in trade accounts receivable and a sluggish inventory unwinding. The unlevered balance sheet remains a safety net, but cash balances have dropped precipitously from $84.3M in Q2 2025 to $25.6M currently.
Stable, slightly down from $135.9 million at year-end 2025. Management had aggressively built inventory to avoid stock-outs during the selling season. While they successfully fulfilled demand (driving the 12% volume growth), a significant amount of cash remains trapped on the balance sheet amid falling market prices.
Guidance
Decelerating. Management explicitly revised this down from their prior target of 'mid-twenty percent.' They cited persistent subdued refrigerant market pricing and sustained inflationary pressures (particularly fuel) expected to last through the close of 2026.
Key Questions
SG&A Normalization Timeline
SG&A jumped 33% this quarter, driven by ERP optimization, consulting, and legal fees. When do you expect these 'temporary' investments to roll off, and what is the normalized quarterly SG&A run-rate heading into 2027?
DLA Contract Protest Update
Legal fees regarding the DLA contract are now actively impacting quarterly SG&A. Can you provide a timeline for a final resolution from the DLA, and what contingency plans are in place if the contract is awarded to a competitor?
Icorium Commercialization
The Icorium partnership for extractive distillation is compelling. What is the expected timeline and capital expenditure required to bring this technology from the pilot phase to commercial scale?
Price Declines vs Volume Gains
You achieved 12% volume growth but saw a 6% price decline. Are you proactively lowering prices to win this volume and clear inventory, or are you strictly following the broader market's price deterioration?